<DOC>
	<DOCNO>NCT01619410</DOCNO>
	<brief_summary>In pilot study , objective determine prevalence asymptomatic carriage S. aureus patient ABSSSIs minor cutaneous abscess therapy either linezolid clindamycin 40 day completion therapy . Secondarily , investigator assess efficacy linezolid vs. clindamycin empiric therapy ABSSSIs minor cutaneous abscess , well genotypic spectrum S. aureus isolates cause ABSSSIs minor cutaneous abscess colonization target patient population therapy . Given result recent study linezolid vancomycin investigator 's experience , hypothesize persistent MRSA carriage less common therapy linezolid ABSSSIs minor cutaneous abscesses oral clindamycin .</brief_summary>
	<brief_title>Asymptomatic Colonization With S. Aureus After Therapy With Linezolid Clindamycin Acute Skin Infections</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases , Bacterial</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<criteria>ABSSSI minor cutaneous abscess treat ED age 18 year old one follow comorbidities : diagnosis diabetes mellitus obesity BMI &gt; 35 chronic kidney disease coronary artery disease peripheral vascular disease know history current thrombocytopenia Currently take antidepression medication Current recent hospitalization Known current alcohol drug abuse Known suspect hypersensitivity ingredient study drug Irregular heart rate blood pressure measurements Fevers low body temperature Known psychiatric condition Superficial skin infection Skin infection cause animal bite Recent treatment antibacterial Pregnancy Other protocol relate inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>